Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
about
Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactionsGrowth hormone promotes hair cell regeneration in the zebrafish (Danio rerio) inner ear following acoustic trauma.Artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is HER2-regulated and mediates acquired trastuzumab resistance by promoting cancer stem cell-like behavior in mammary carcinoma cells.Chicken oviduct-the target tissue for growth hormone action: effect on cell proliferation and apoptosis and on the gene expression of some oviduct-specific proteins.Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 ExpressionTrefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24.Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaGrowth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complexAutocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma.Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinomaEvaluation of growth hormone (GH) action in mice: discovery of GH receptor antagonists and clinical indications.Extrapituitary production of anterior pituitary hormones: an overview.Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells.Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways.Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells.Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma.MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer.Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps.Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer.Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells
P2860
Q28082801-CBA73779-1808-46B8-97F1-729FEFE57B7BQ30472446-FDEEFC82-A74A-4A25-8B04-D5F24C4ED3F5Q33718457-88E1FB6E-7CCE-4871-B164-D9CBAFF39681Q33829137-2CFB6A96-395E-44D4-8BEB-2F56EB9E1BCEQ33838977-78DC8435-9829-42F4-8986-F1057490692AQ33889185-4B075695-1288-4066-B7B9-DE2419AC2A88Q34041350-0B36D0C0-65FD-4F72-A0F2-76D06D1ABAD3Q34411725-89F065CB-77DB-4079-87E8-514ECBE8CEA4Q34712091-2AD11DDE-C1EF-4EC7-80B1-E2340141EC7FQ35662272-C045BBC0-4E36-4D8B-9033-47F57D5C925DQ35889585-DFEA9DF3-DC0C-46D4-B83C-307D80C2010AQ36152945-4551DA40-E362-4522-AC6F-F4DC2880487AQ36772115-4D548F75-295B-43AF-837F-67EAA1338DE1Q37301860-54F47378-080D-4C22-B0A4-7D31937D38E2Q37619460-240A8E5B-F1D1-4845-B343-8D42C859CE09Q37968477-E64AE262-1587-4B70-B6D3-8A617E5515EBQ38904753-740C27CB-424E-4E81-A1AF-664A1FB6CE60Q39658606-EDC8771A-C65A-4B0C-B93C-F48D7555A0C4Q42290800-AF738D7C-2EFD-4A01-B64E-C41726595D09Q46476983-89F7A80A-F73F-47A9-B05A-9A03A0D7FF1FQ47107528-E028DDB2-6FE3-4C45-A718-912056FCD470Q47138409-CF78F5AC-C3E8-4E38-90F1-5385C7ECA7A3Q48128794-FC9E55B4-0FF8-4258-9429-2EBD70799450Q48373900-FFFD5E14-3C6E-44D1-9571-E0C6A0FBEB53Q55654447-CBC394DA-D8D6-47B8-A980-49CC2FE45C52Q59126395-52F4FAFD-505C-4C64-B7A9-FA836C34C591
P2860
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
@en
type
label
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
@en
prefLabel
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
@en
P2093
P2860
P356
P1433
P1476
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells
@en
P2093
Kumarasamypet M Mohankumar
Peter E Lobie
Shu-Min Liu
Vijay Pandey
Xiang-Jun Kong
Zheng-Sheng Wu
P2860
P304
P356
10.1210/EN.2008-0286
P407
P577
2008-05-01T00:00:00Z